Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic.

Soukupová J, Lhotová K, Zemánková P, Vočka M, Janatová M, Stolařová L, Borecká M, Kleiblová P, Macháčková E, Foretová L, Koudová M, Lhota F, Tavandzis S, Zikán M, Stránecký V, Veselá K, Panczak A, Kotlas J, Kleibl Z.

Klin Onkol. 2019 Summer;32(Supplementum2):72-78. doi: 10.14735/amko2019S72.

PMID:
31409082
2.

Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.

Kleiblová P, Stolařová L, Křížová K, Lhota F, Hojný J, Zemánková P, Havránek O, Vočka M, Černá M, Lhotová K, Borecká M, Janatová M, Soukupová J, Ševčík J, Zimovjanová M, Kotlas J, Panczak A, Veselá K, Červenková J, Schneiderová M, Burócziová M, Burdová K, Stránecký V, Foretová L, Macháčková E, Tavandzis S, Kmoch S, Macůrek L, Kleibl Z.

Klin Onkol. 2019 Summer;32(Supplementum2):36-50. doi: 10.14735/amko2019S36.

PMID:
31409080
3.

Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers.

Vocka M, Zimovjanova M, Bielcikova Z, Tesarova P, Petruzelka L, Mateju M, Krizova L, Kotlas J, Soukupova J, Janatova M, Zemankova P, Kleiblova P, Novotny J, Konopasek B, Chodacka M, Brychta M, Sochor M, Smejkalova-Musilova D, Cmejlova V, Kozevnikovova R, Miskarova L, Argalacsova S, Stolarova L, Lhotova K, Borecka M, Kleibl Z.

Cancers (Basel). 2019 May 28;11(6). pii: E738. doi: 10.3390/cancers11060738.

4.

Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer.

Kleiblova P, Stolarova L, Krizova K, Lhota F, Hojny J, Zemankova P, Havranek O, Vocka M, Cerna M, Lhotova K, Borecka M, Janatova M, Soukupova J, Sevcik J, Zimovjanova M, Kotlas J, Panczak A, Vesela K, Cervenkova J, Schneiderova M, Burocziova M, Burdova K, Stranecky V, Foretova L, Machackova E, Tavandzis S, Kmoch S, Macurek L, Kleibl Z.

Int J Cancer. 2019 Oct 1;145(7):1782-1797. doi: 10.1002/ijc.32385. Epub 2019 May 20.

PMID:
31050813
5.

Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations.

Lovecek M, Janatova M, Skalicky P, Zemanek T, Havlik R, Ehrmann J, Strouhal O, Zemankova P, Lhotova K, Borecka M, Soukupova J, Svebisova H, Soucek P, Hlavac V, Kleibl Z, Neoral C, Melichar B, Mohelnikova-Duchonova B.

Cancer Manag Res. 2019 Jan 10;11:599-609. doi: 10.2147/CMAR.S185352. eCollection 2019.

6.

Novel assay for the toxicity evaluation of nanoscale zero-valent iron and derived nanomaterials based on lipid peroxidation in bacterial species.

Semerád J, Čvančarová M, Filip J, Kašlík J, Zlotá J, Soukupová J, Cajthaml T.

Chemosphere. 2018 Dec;213:568-577. doi: 10.1016/j.chemosphere.2018.09.029. Epub 2018 Sep 13.

PMID:
30268053
7.

BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.

Burke LJ, Sevcik J, Gambino G, Tudini E, Mucaki EJ, Shirley BC, Whiley P, Parsons MT, De Leeneer K, Gutiérrez-Enríquez S, Santamariña M, Caputo SM, Santana Dos Santos E, Soukupova J, Janatova M, Zemankova P, Lhotova K, Stolarova L, Borecka M, Moles-Fernández A, Manoukian S, Bonanni B; ENIGMA Consortium, Edwards SL, Blok MJ, van Overeem Hansen T, Rossing M, Diez O, Vega A, Claes KBM, Goldgar DE, Rouleau E, Radice P, Peterlongo P, Rogan PK, Caligo M, Spurdle AB, Brown MA.

Hum Mutat. 2018 Dec;39(12):2025-2039. doi: 10.1002/humu.23652. Epub 2018 Sep 24.

8.

Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.

Soukupova J, Zemankova P, Lhotova K, Janatova M, Borecka M, Stolarova L, Lhota F, Foretova L, Machackova E, Stranecky V, Tavandzis S, Kleiblova P, Vocka M, Hartmannova H, Hodanova K, Kmoch S, Kleibl Z.

PLoS One. 2018 Apr 12;13(4):e0195761. doi: 10.1371/journal.pone.0195761. eCollection 2018.

9.

Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression.

Rani B, Malfettone A, Dituri F, Soukupova J, Lupo L, Mancarella S, Fabregat I, Giannelli G.

Cell Death Dis. 2018 Mar 7;9(3):373. doi: 10.1038/s41419-018-0384-5.

10.

Resminostat induces changes in epithelial plasticity of hepatocellular carcinoma cells and sensitizes them to sorafenib-induced apoptosis.

Soukupova J, Bertran E, Peñuelas-Haro I, Urdiroz-Urricelqui U, Borgman M, Kohlhof H, Fabregat I.

Oncotarget. 2017 Nov 30;8(66):110367-110379. doi: 10.18632/oncotarget.22775. eCollection 2017 Dec 15.

11.

Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.

Nielsen SM, Eccles DM, Romero IL, Al-Mulla F, Balmaña J, Biancolella M, Bslok R, Caligo MA, Calvello M, Capone GL, Cavalli P, Chan TLC, Claes KBM, Cortesi L, Couch FJ, de la Hoya M, De Toffol S, Diez O, Domchek SM, Eeles R, Efremidis A, Fostira F, Goldgar D, Hadjisavvas A, Hansen TVO, Hirasawa A, Houdayer C, Kleiblova P, Krieger S, Lázaro C, Loizidou M, Manoukian S, Mensenkamp AR, Moghadasi S, Monteiro AN, Mori L, Morrow A, Naldi N, Nielsen HR, Olopade OI, Pachter NS, Palmero EI, Pedersen IS, Piane M, Puzzo M, Robson M, Rossing M, Sini MC, Solano A, Soukupova J, Tedaldi G, Teixeira M, Thomassen M, Tibiletti MG, Toland A, Törngren T, Vaccari E, Varesco L, Vega A, Wallis Y, Wappenschmidt B, Weitzel J, Spurdle AB, De Nicolo A, Gómez-García EB.

JCO Precis Oncol. 2018;2. doi: 10.1200/PO.18.00091. Epub 2018 Oct 26.

12.

Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism.

Soukupova J, Malfettone A, Hyroššová P, Hernández-Alvarez MI, Peñuelas-Haro I, Bertran E, Junza A, Capellades J, Giannelli G, Yanes O, Zorzano A, Perales JC, Fabregat I.

Sci Rep. 2017 Oct 2;7(1):12486. doi: 10.1038/s41598-017-12837-y.

13.

Multiplex PCR and NGS-based identification of mRNA splicing variants: Analysis of BRCA1 splicing pattern as a model.

Hojny J, Zemankova P, Lhota F, Sevcik J, Stranecky V, Hartmannova H, Hodanova K, Mestak O, Pavlista D, Janatova M, Soukupova J, Vocka M, Kleibl Z, Kleiblova P.

Gene. 2017 Dec 30;637:41-49. doi: 10.1016/j.gene.2017.09.025. Epub 2017 Sep 14.

PMID:
28919163
14.

Hybrid polymeric-protein nano-carriers (HPPNC) for targeted delivery of TGFβ inhibitors to hepatocellular carcinoma cells.

Hanafy NAN, Quarta A, Di Corato R, Dini L, Nobile C, Tasco V, Carallo S, Cascione M, Malfettone A, Soukupova J, Rinaldi R, Fabregat I, Leporatti S.

J Mater Sci Mater Med. 2017 Aug;28(8):120. doi: 10.1007/s10856-017-5930-7. Epub 2017 Jul 6.

PMID:
28685231
15.

Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.

Malfettone A, Soukupova J, Bertran E, Crosas-Molist E, Lastra R, Fernando J, Koudelkova P, Rani B, Fabra Á, Serrano T, Ramos E, Mikulits W, Giannelli G, Fabregat I.

Cancer Lett. 2017 Apr 28;392:39-50. doi: 10.1016/j.canlet.2017.01.037. Epub 2017 Feb 2.

PMID:
28161507
16.

RE: frameshift variant FANCL*c.1096_1099dupATTA is not associated with high breast cancer risk.

Zemankova P, Lhota F, Kleiblova P, Soukupova J, Vocka M, Janatova M, Kleibl Z.

Clin Genet. 2016 Oct;90(4):387-9. doi: 10.1111/cge.12842. No abstract available.

PMID:
27659787
17.

The c.657del5 variant in the NBN gene predisposes to pancreatic cancer.

Borecka M, Zemankova P, Lhota F, Soukupova J, Kleiblova P, Vocka M, Soucek P, Ticha I, Kleibl Z, Janatova M.

Gene. 2016 Aug 10;587(2):169-72. doi: 10.1016/j.gene.2016.04.056. Epub 2016 May 2.

PMID:
27150568
18.

Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic.

Borecka M, Zemankova P, Vocka M, Soucek P, Soukupova J, Kleiblova P, Sevcik J, Kleibl Z, Janatova M.

Cancer Genet. 2016 May;209(5):199-204. doi: 10.1016/j.cancergen.2016.03.003. Epub 2016 Apr 5.

PMID:
27106063
19.

New Insights into the Crossroads between EMT and Stemness in the Context of Cancer.

Fabregat I, Malfettone A, Soukupova J.

J Clin Med. 2016 Mar 12;5(3). pii: E37. doi: 10.3390/jcm5030037. Review.

20.

Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients.

Lhota F, Zemankova P, Kleiblova P, Soukupova J, Vocka M, Stranecky V, Janatova M, Hartmannova H, Hodanova K, Kmoch S, Kleibl Z.

Clin Genet. 2016 Oct;90(4):324-33. doi: 10.1111/cge.12748. Epub 2016 Mar 4.

PMID:
26822949
21.

Microscale Rockets and Picoliter Containers Engineered from Electrospun Polymeric Microtubes.

Sitt A, Soukupova J, Miller D, Verdi D, Zboril R, Hess H, Lahann J.

Small. 2016 Mar;12(11):1432-9. doi: 10.1002/smll.201503467. Epub 2016 Jan 21.

PMID:
26797691
23.

[PALB2 as Another Candidate Gene for Genetic Testing in Patients with Hereditary Breast Cancer in Czech Republic].

Janatová M, Borecká M, Soukupová J, Kleiblová P, Stříbrná J, Vočka M, Zemánková P, Panczak A, Veselá K, Souček P, Foretová L, Kleibl Z.

Klin Onkol. 2016;29 Suppl 1:S31-4. Czech.

PMID:
26691940
24.

Reprint of: Cytotoxicity, cell uptake and microscopic analysis of titanium dioxide and silver nanoparticles in vitro.

Tomankova K, Horakova J, Harvanova M, Malina L, Soukupova J, Hradilova S, Kejlova K, Malohlava J, Licman L, Dvorakova M, Jirova D, Kolarova H.

Food Chem Toxicol. 2015 Nov;85:20-30. doi: 10.1016/j.fct.2015.10.012. Epub 2015 Nov 1.

PMID:
26518667
25.

Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic.

Janatova M, Soukupova J, Stribrna J, Kleiblova P, Vocka M, Boudova P, Kleibl Z, Pohlreich P.

PLoS One. 2015 Jun 9;10(6):e0127711. doi: 10.1371/journal.pone.0127711. eCollection 2015.

26.

Cytotoxicity, cell uptake and microscopic analysis of titanium dioxide and silver nanoparticles in vitro.

Tomankova K, Horakova J, Harvanova M, Malina L, Soukupova J, Hradilova S, Kejlova K, Malohlava J, Licman L, Dvorakova M, Jirova D, Kolarova H.

Food Chem Toxicol. 2015 Aug;82:106-15. doi: 10.1016/j.fct.2015.03.027. Epub 2015 Apr 3.

PMID:
25846500
27.

Silver nanoparticles modified by gelatin with extraordinary pH stability and long-term antibacterial activity.

Sivera M, Kvitek L, Soukupova J, Panacek A, Prucek R, Vecerova R, Zboril R.

PLoS One. 2014 Aug 6;9(8):e103675. doi: 10.1371/journal.pone.0103675. eCollection 2014.

28.

Jumping-like translocation-a rare chromosomal rearrangement in a patient with Burkitt lymphoma/leukemia.

Sarova I, Brezinova J, Lhotska H, Berkova A, Ransdorfova S, Zemanova Z, Soukupova J, Michalova K.

Cancer Genet. 2014 May;207(5):221-5. doi: 10.1016/j.cancergen.2014.05.001. Epub 2014 May 10.

PMID:
24957271
29.

The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.

Janatova M, Kleibl Z, Stribrna J, Panczak A, Vesela K, Zimovjanova M, Kleiblova P, Dundr P, Soukupova J, Pohlreich P.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2323-32. doi: 10.1158/1055-9965.EPI-13-0745-T. Epub 2013 Oct 17.

30.

Fusion of the additional sex combs like 1 and teashirt zinc finger homeobox 2 genes resulting from ider(20q) aberration in a patient with myelodysplastic syndrome.

Brezinova J, Sarova I, Buryova H, Markova J, Ransdorfova S, Izakova S, Kostylkova K, Soukupova J, Zemanova Z, Michalova K.

Br J Haematol. 2014 Jan;164(1):153-5. doi: 10.1111/bjh.12586. Epub 2013 Oct 10. No abstract available.

PMID:
24117282
31.

Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors.

Wakefield A, Soukupova J, Montagne A, Ranger J, French R, Muller WJ, Clarkson RW.

Cancer Res. 2013 Jan 15;73(2):745-55. doi: 10.1158/0008-5472.CAN-12-1321. Epub 2012 Nov 13.

32.

[The clinical importance of a genetic analysis of moderate-risk cancer susceptibility genes in breast and other cancer patients from the Czech Republic].

Pohlreich P, Kleibl Z, Kleiblová P, Janatová M, Soukupová J, Macháčková E, Házová J, Vašíčková P, Sťahlová Hrabincová E, Navrátilová M, Svoboda M, Foretová L.

Klin Onkol. 2012;25 Suppl:S59-66. Review. Czech.

PMID:
22920209
33.

Germline mutations 657del5 and 643C>T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women.

Mateju M, Kleiblova P, Kleibl Z, Janatova M, Soukupova J, Ticha I, Novotny J, Pohlreich P.

Breast Cancer Res Treat. 2012 Jun;133(2):809-11. doi: 10.1007/s10549-012-2049-x. Epub 2012 Apr 11. No abstract available.

PMID:
22491912
34.

Characterisation of ATM mutations in Slavic Ataxia telangiectasia patients.

Soukupova J, Pohlreich P, Seemanova E.

Neuromolecular Med. 2011 Sep;13(3):204-11. doi: 10.1007/s12017-011-8152-z. Epub 2011 Aug 11.

PMID:
21833744
35.

The AIB1 gene polyglutamine repeat length polymorphism and the risk of breast cancer development.

Kleibl Z, Havranek O, Kormunda S, Novotny J, Foretova L, Machackova E, Soukupova J, Janatova M, Tavandzis S, Pohlreich P.

J Cancer Res Clin Oncol. 2011 Feb;137(2):331-8. doi: 10.1007/s00432-010-0889-5. Epub 2010 Apr 27.

PMID:
20422428
36.

Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer.

Brahemi G, Kona FR, Fiasella A, Buac D, Soukupová J, Brancale A, Burger AM, Westwell AD.

J Med Chem. 2010 Apr 8;53(7):2757-65. doi: 10.1021/jm901757t.

37.

Antifungal activity of silver nanoparticles against Candida spp.

Panácek A, Kolár M, Vecerová R, Prucek R, Soukupová J, Krystof V, Hamal P, Zboril R, Kvítek L.

Biomaterials. 2009 Oct;30(31):6333-40. doi: 10.1016/j.biomaterials.2009.07.065. Epub 2009 Aug 20.

PMID:
19698988
38.

Synergy of serum and cerebrospinal fluid antibodies against axonal cytoskeletal proteins in patients with different neurological diseases.

Fialová L, Bartos A, Soukupová J, Svarcová J, Ridzon P, Malbohan I.

Folia Biol (Praha). 2009;55(1):23-6.

39.

Comment on 'Preparation and antibacterial activity of Fe3O4@Ag nanoparticles'.

Kvítek L, Soukupova J.

Nanotechnology. 2009 Jan 14;20(2):028001. doi: 10.1088/0957-4484/20/2/028001. Epub 2008 Dec 11.

PMID:
19417286
40.

Contribution of mutations in ATM to breast cancer development in the Czech population.

Soukupova J, Dundr P, Kleibl Z, Pohlreich P.

Oncol Rep. 2008 Jun;19(6):1505-10.

PMID:
18497957
41.

Early detection of bean infection by Pseudomonas syringae in asymptomatic leaf areas using chlorophyll fluorescence imaging.

Rodríguez-Moreno L, Pineda M, Soukupová J, Macho AP, Beuzón CR, Barón M, Ramos C.

Photosynth Res. 2008 Apr;96(1):27-35. Epub 2007 Nov 14.

PMID:
18000760
42.

Antibodies against light neurofilaments in multiple sclerosis patients.

Bartos A, Fialová L, Soukupová J, Kukal J, Malbohan I, Pitha J.

Acta Neurol Scand. 2007 Aug;116(2):100-7.

PMID:
17661795
43.

Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis.

Bartos A, Fialová L, Soukupová J, Kukal J, Malbohan I, Pit'ha J.

J Neurol. 2007 Jan;254(1):20-5. Epub 2007 Feb 14.

PMID:
17508137
44.

Carbonyl and oxidative stress in patients with breast cancer--is there a relation to the stage of the disease?

Tesarová P, Kalousová M, Trnková B, Soukupová J, Argalásová S, Mestek O, Petruzelka L, Zima T.

Neoplasma. 2007;54(3):219-24.

PMID:
17447853
45.

Direct evidence of plant-pathogenic activity of fungal metabolites of Trichothecium roseum on apple.

Zabka M, Drastichová K, Jegorov A, Soukupová J, Nedbal L.

Mycopathologia. 2006 Jul;162(1):65-8.

PMID:
16830194
46.

Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.

Hodkova M, Dusilova-Sulkova S, Kalousova M, Soukupova J, Zima T, Mikova D, Malbohan IM, Bartunkova J.

Ren Fail. 2006;28(5):395-9.

PMID:
16825088
47.

Pregnancy-associated plasma protein-A in patients with cerebrovascular diseases--a pilot study.

Fialová L, Pilecková N, Bauer J, Soukupová J, Kalousová M, Malbohan I, Pernický A, Kraml P, Zima T.

Prague Med Rep. 2006;107(1):37-45.

PMID:
16752802
48.

Oxidative stress and inflammation in pregnancy.

Fialová L, Malbohan I, Kalousová M, Soukupová J, Krofta L, Stípek S, Zima T.

Scand J Clin Lab Invest. 2006;66(2):121-7.

PMID:
16537245
49.

Kinetic imaging of chlorophyll fluorescence using modulated light.

Nedbal L, Soukupová J, Kaftan D, Whitmarsh J, Trtílek M.

Photosynth Res. 2000;66(1-2):3-12.

PMID:
16228406
50.

[Advanced glycation and oxidation products in patients with atherosclerosis].

Kalousová M, Zák A, Soukupová J, Stípek S, Malbohan IM, Zima T.

Cas Lek Cesk. 2005;144(6):385-9; discussion 389-90. Czech.

PMID:
16047840

Supplemental Content

Loading ...
Support Center